| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |
|
|
|
|
|||||||||||||
|
|
|||||||||||||||
RESEARCH PAPER |
1 Department of Clinical Pharmacy, Institute for Health Policy Studies, University of California, San Francisco, San Francisco, California, USA
2 Center for Tobacco Control Research and Education, University of California, San Francisco
3 Public Administration Analyst, Department of Clinical Pharmacy & Center for Tobacco Control Research and Education, University of California, San Francisco
Correspondence to:
Lisa A Bero PhD
University of California, 3333 California Street, Suite 420, Box 0613, San Francisco, CA 94143-0613 (94118 for express mail only), USA; bero{at}medicine.ucsf.edu
Objective: To assess the effectiveness of conflict of interest disclosure policies by comparing a competing interests disclosure statement that met the requirements established by the journal in a 2003 article on health effects of secondhand smoke based on the American Cancer Society CPS-I dataset with internal tobacco industry documents describing financial ties between the tobacco industry and authors of the study.
Design: Descriptive analysis of internal tobacco industry documents retrieved from the Legacy Tobacco Documents Library, University of California, San Francisco.
Results: Meeting the requirements for financial disclosure established by the journal did not provide the reader with a full picture of the tobacco industry’s involvement with the study authors. The tobacco industry documents reveal that the authors had long standing financial and other working relationships with the tobacco industry.
Conclusion: These findings are another example of how simply requiring authors to disclose financial ties with the tobacco industry may not be adequate to give readers (and reviewers) a full picture of the author’s relationship with the tobacco industry. The documents also reveal that the industry funds research to enhance its credibility and endeavours to work with respected scientists to advance its goals. These findings question the adequacy of current journal policies regarding competing interest disclosures and the acceptability of tobacco industry funding for academic research.
Abbreviations: ACS, American Cancer Society; BMJ, British Medical Journal; CIAR, Center for Indoor Air Research; CPS, Cancer Prevention Study; CTR, Council for Tobacco Research; JAMA, Journal of the American Medical Association; SRRC, Philip Morris scientific research review committee; TRDRP, California Tobacco-Related Disease Research Program
Keywords: academic industry relations; conflict of interest; tobacco smoke pollution
This article has been cited by other articles:
|
|
 |
|
  E. K. Tong and S. A. Glantz Tobacco Industry Efforts Undermining Evidence Linking Secondhand Smoke With Cardiovascular Disease Circulation, October 16, 2007; 116(16): 1845 - 1854. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N Hirschhorn, S A. Bialous, and S Shatenstein The Philip Morris External Research Program: results from the first round of projects Tob. Control, June 1, 2006; 15(3): 267 - 269. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. A Smith, N. Offen, and R. E Malone What makes an ad a cigarette ad? Commercial tobacco imagery in the lesbian, gay, and bisexual press J. Epidemiol. Community Health, December 1, 2005; 59(12): 1086 - 1091. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S Chapman Research from tobacco industry affiliated authors: need for particular vigilance Tob. Control, August 1, 2005; 14(4): 217 - 219. [Full Text] [PDF]
|
|
|
|
 |
|
 A. Baba, D. M. Cook, T. O. McGarity, and L. A. Bero Legislating "Sound Science": The Role of the Tobacco Industry Am J Public Health, July 1, 2005; 95(S1): S20 - S27. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |
